Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Shares Outstanding (Weighted Average): 2017-2019

Historic Shares Outstanding (Weighted Average) for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to $2.0 million.

  • Astria Therapeutics' Shares Outstanding (Weighted Average) rose 66.07% to $2.0 million in Q4 2019 from the same period last year, while for Sep 2019 it was $1.9 million, marking a year-over-year increase of 63.53%. This contributed to the annual value of $56.4 million for FY2024, which is 55.48% up from last year.
  • Astria Therapeutics' Shares Outstanding (Weighted Average) amounted to $2.0 million in Q4 2019, which was up 1.55% from $1.9 million recorded in Q3 2019.
  • Astria Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $2.0 million for Q4 2019, and its period low was $314,976 during Q1 2017.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $833,951 (2018), whereas its average is $1.0 million.
  • Data for Astria Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 296.02% (in 2019) over the last 5 years.
  • Astria Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $384,720 in 2017, then spiked by 207.75% to $1.2 million in 2018, then skyrocketed by 66.07% to $2.0 million in 2019.
  • Its Shares Outstanding (Weighted Average) was $2.0 million in Q4 2019, compared to $1.9 million in Q3 2019 and $1.9 million in Q2 2019.